EBITDA

Audio-toy maker tonies® appoints a Mattel veteran to lead its largest market, signaling a strategy to deepen its US hold and scale globally.

A novel drug candidate from Addex Therapeutics shows robust cough suppression in key preclinical studies, offering hope for a treatment without current side effects.

Arçelik secures up to $261M by selling its Hitachi JV stake, part of a larger deal that sees retailer Nojima acquire Hitachi's entire appliance arm.

With record global attendance and a focus on AI, drones, and sustainability, CCE 2026 in Shanghai showcased a cleaning industry in radical transformation.

The Japanese IT giant launches a new investment arm in Singapore, joining a wave of corporate capital chasing growth and innovation in the region's booming tech sector.

The acquisition of Canadian favorite Libro gives OpenTable a Quebec stronghold, but will local restaurants embrace the global giant's embrace?

As IPO markets revive, advisory firms say patient private equity capital and rigorous prep are the keys for companies hoping to go public successfully.

California's largest water coalition is demanding a fundamental overhaul of the state's water system, setting the stage for a major political battle in 2026.

Millions suffer from osteoporosis, but many refuse injections. Now, a biotech company's oral pill aims to bridge a massive treatment gap. Here's how.

With a history of strong growth but a volatile stock, Paymentus's upcoming Q1 2026 earnings report on May 4 is a critical moment for investors.

Marigold appoints a new Chief AI Officer and CPTO, signaling a major strategic push to embed advanced intelligence across its marketing platforms.

With 26 new MLS partnerships, Restb.ai's embedded AI is now used by over a million agents, automating tasks and transforming property data behind the scenes.

Tiger Data's new self-managed database brings modern, open-source power to critical industries, challenging the reign of legacy data historian platforms.

DecisionHR hires PEO veteran Josh McIntosh as CRO, signaling a strategic push for market share in the booming, competitive HR outsourcing industry.

Freshly spun-off from AnaptysBio, First Tracks Biotherapeutics hits the market with a strong cash position and a pipeline aimed at celiac disease and RA.

As crypto traders drown in data, DSCVR's new AI subscription promises to turn noise into actionable intelligence. Is this the future of Web3 investing?

As pay transparency and economic pressures mount, a new unified platform aims to democratize compensation intelligence across the entire organization.

Atsena Therapeutics gets the green light for the final trial phase of a promising gene therapy, offering the first real hope for patients with X-linked retinoschisis.

The B2B media giant expands its data-driven model to the UK's lucrative financial services sector, leveraging AI-era content strategies for growth.

A new comparison reveals stark differences in SDK generators, showing the shift from developer tools to critical infrastructure for security, compliance, and AI.